相关实验视频

Updated: Jan 9, 2026

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Published on: January 27, 2018

工程结合素XVII装载的溶解微针贴片,用于促进雄激素脱发症的头发再生

Tao Ye¹, Chunna Wu¹, Yufei Fan¹

¹Department of Cell Biology, Jinan University, Guangzhou 510632, China.

Regenerative biomaterials

|December 11, 2025

概括

原XVII (COL17) 降低调节是雄激素性脱发症 (AGA) 的关键. 微针传递的COL17片段 (rhCOL17p) 通过激活干细胞通路,有效地促进头发再生,为脱发提供了一个有前途的新疗法.

科学领域:

皮肤病学和再生医学
生物技术和药物输送生物技术和药物输送

背景情况:

雄激素性脱毛症 (AGA) 显著影响生活质量,目前的治疗方法,如米诺克西迪尔,在符合性和有效性方面面临限制.
确定原XVII (COL17) 降低调节是AGA发病的关键因素,与毛囊形态异常和血管生成受损有关.

研究的目的:

研究COL17在AGA中的作用,并使用通过微针 (MN) 贴片输送的重组人体COL17片段 (rhCOL17p) 开发一种新的治疗策略.

主要方法:

从大肠杆菌中开发和净化了rhCOL17p.
创建了溶解氨酸微针 (MN) 贴片,用于通过皮肤输送rhCOL17p.
在AGA小鼠模型中,评估了rhCOL17p在体外 (细胞增殖,粘附,迁移) 和体内 (毛发再生,毛囊密度,血管化) 的疗效.

主要成果:

rhCOL17p在体外增强了皮肤乳头细胞功能.
rhCOL17p-MN贴片表现出高度的皮肤透和持续释放,显著的毛发覆盖 (~97%) 和体内毛囊密度增加,与米诺克西迪尔相当.
组织学分析显示,毛囊结构恢复,干细胞信号通路 (β-catenin,SOX9) 激活,安全性较好 (低血解,良好的机械稳定性).

结论:

COL17下调是AGA的一个关键机制.
微针输送的 rhCOL17p 通过多通道调节有效促进头发再生.
rhCOL17p-MN为AGA治疗提供了一个安全和可行的临床前候选者.

关键词:

安卓质脱发症 (androgenic alopecia) 是一种头发再生头发的再生微针贴片微针贴片复合人体原XVII复合人体原XVII

更多相关视频

Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability

Author Spotlight: Innovative Microneedle-Based Strategies for Enhanced Exosome Delivery and Stability

Published on: July 12, 2024

Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model

Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model

Published on: February 7, 2018

相关概念视频

Tissue Renewal without Stem Cells

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...

Renewal of Skin Epidermal Stem Cells

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...